Follow-The-Filings

Security · featured owners

TVRD Tvardi Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

TVRD (Tvardi Therapeutics Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 21,438 $68K history

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 8.01 Filing Doc
424B3 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B3 Filing Doc
S-1/A Filing Doc
8-K 8.01,9.01 Filing Doc
S-1/A Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Jun 9, 2026 · 5 forms Filing Doc
4 Period Jan 29, 2026 · 4 forms Filing Doc
4 Period Dec 16, 2025 · 4 forms Filing Doc
4 Period Jul 7, 2025 Filing Doc

Updated 26 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $20.97M $7.14M —
Net income -$118.51M -$70.87M -$18.21M
Net margin * -565.2% -993.0% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $116.16M $43.83M $31.54M
Total non-current assets * $9.69M $0M $0.535M
Total assets $125.84M $43.83M $32.07M
Total current liabilities $25.59M $3.97M $11.04M
Total non-current liabilities * $43.17M $44.45M $0.085M
Total equity $57.08M -$4.59M $20.95M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$92.08M -$60.92M -$23.5M
Cash from investing $43.46M $48.74M -$10.08M
Cash from financing $38.15M -$3.6M $22.7M
Net change in cash * -$10.47M -$15.78M -$10.88M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders